1. Home
  2. TBBK vs LMAT Comparison

TBBK vs LMAT Comparison

Compare TBBK & LMAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TBBK
  • LMAT
  • Stock Information
  • Founded
  • TBBK 1999
  • LMAT 1983
  • Country
  • TBBK United States
  • LMAT United States
  • Employees
  • TBBK N/A
  • LMAT N/A
  • Industry
  • TBBK Major Banks
  • LMAT Medical/Dental Instruments
  • Sector
  • TBBK Finance
  • LMAT Health Care
  • Exchange
  • TBBK Nasdaq
  • LMAT Nasdaq
  • Market Cap
  • TBBK 2.4B
  • LMAT 1.9B
  • IPO Year
  • TBBK 2004
  • LMAT 2006
  • Fundamental
  • Price
  • TBBK $65.04
  • LMAT $84.68
  • Analyst Decision
  • TBBK Buy
  • LMAT Buy
  • Analyst Count
  • TBBK 3
  • LMAT 6
  • Target Price
  • TBBK $65.33
  • LMAT $100.80
  • AVG Volume (30 Days)
  • TBBK 550.0K
  • LMAT 152.3K
  • Earning Date
  • TBBK 07-24-2025
  • LMAT 08-05-2025
  • Dividend Yield
  • TBBK N/A
  • LMAT 0.96%
  • EPS Growth
  • TBBK 20.50
  • LMAT 30.45
  • EPS
  • TBBK 4.42
  • LMAT 1.97
  • Revenue
  • TBBK $502,282,000.00
  • LMAT $226,256,000.00
  • Revenue This Year
  • TBBK N/A
  • LMAT $13.88
  • Revenue Next Year
  • TBBK $6.71
  • LMAT $8.81
  • P/E Ratio
  • TBBK $14.28
  • LMAT $42.49
  • Revenue Growth
  • TBBK 10.02
  • LMAT 13.19
  • 52 Week Low
  • TBBK $40.51
  • LMAT $71.42
  • 52 Week High
  • TBBK $65.84
  • LMAT $109.58
  • Technical
  • Relative Strength Index (RSI)
  • TBBK 76.14
  • LMAT 50.89
  • Support Level
  • TBBK $55.58
  • LMAT $82.76
  • Resistance Level
  • TBBK $63.70
  • LMAT $86.94
  • Average True Range (ATR)
  • TBBK 1.99
  • LMAT 2.10
  • MACD
  • TBBK 0.71
  • LMAT 0.18
  • Stochastic Oscillator
  • TBBK 95.13
  • LMAT 47.92

About TBBK The Bancorp Inc

The Bancorp Inc is a financial holding company. The Company's operations are classified under three segments: fintech, specialty finance (three sub-segments), and corporate. The fintech segment includes the deposit balances and non-interest income generated by prepaid, debit, and other card-accessed accounts, ACH processing, and other payments-related processing. It also includes loan balances and interest and non-interest income from credit products generated through payment relationships; Specialty finance includes REBL (real estate bridge lending) comprised of apartment building rehabilitation loans, and Others; Corporate includes the Company's investment securities, corporate overhead, and expenses which have not been allocated to segments.

About LMAT LeMaitre Vascular Inc.

LeMaitre Vascular Inc manufactures and distributes medical devices for the treatment of peripheral vascular disease. Its products are used during open vascular surgery and address several anatomical areas, such as the carotid, lower extremities, upper extremities, and aorta. The firm's lower extremities product line contributes towards the proportion of revenue, followed by the carotid product line. LeMaitre's surgical devices include angioscopes, balloon catheters, carotid shunts, phlebectomy devices, vascular grafts, vascular patches, and vessel closure systems. LeMaitre generates the majority of its revenue in the United States.

Share on Social Networks: